scispace - formally typeset
X

Xosé R. Bustelo

Researcher at University of Salamanca

Publications -  167
Citations -  12352

Xosé R. Bustelo is an academic researcher from University of Salamanca. The author has contributed to research in topics: GTPase & Signal transduction. The author has an hindex of 55, co-authored 156 publications receiving 11522 citations. Previous affiliations of Xosé R. Bustelo include Harvard University & Bristol-Myers Squibb.

Papers
More filters
Journal ArticleDOI

Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.

TL;DR: The optimal recognition motifs for SH2 domains from GRB-2, Drk, Csk, Vav, fps/fes, SHC, SYk, Syk (carboxy-terminal SH2), 3BP2, and HCP are reported here.
Journal ArticleDOI

S. typhimurium Encodes an Activator of Rho GTPases that Induces Membrane Ruffling and Nuclear Responses in Host Cells

TL;DR: This work shows that SopE, a substrate of this secretion system, stimulates cytoskeletal reorganization and JNK activation in a CDC42- and Rac-1-dependent manner, and establishes a paradigm for microbial stimulation of cellular responses in which the pathogen induces signaling events by directly engaging the signaling machinery within the host cell.
Journal ArticleDOI

Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product

TL;DR: The results have identified a function for Vav and define a mechanism in which engaged membrane receptors activate its signalling pathway, causing this GTPase to switch from its inactive to its active state.
Journal ArticleDOI

GTP‐binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo

TL;DR: An overview on the recent advances in this field regarding the mechanism of regulation and signaling, and the roles in vivo of this important GTPase family is provided.
Journal ArticleDOI

Regulatory and Signaling Properties of the Vav Family

TL;DR: This work is supported by the National Cancer Institute (CA7373501), the Baldwin Foundation for Breast Cancer Research, and the Association for International Cancer Research.